CIK: 1454996 - Address: 10170 Church Ranch Way, Suite 100, Westminster, CO 80021
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1161-3-2-16-24-39-14
S%wins50835010010010081

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/23/21 16:53
11/22/21
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOS.VP,GCP1132.26050999%51D
4/5/17 16:15
4/4/17
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOS.VP,GCS-12.4100-218D-61-31-13-10-6-2-8-4405
3/1/17 17:11
2/28/17
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOS.VP,GCS.d-12.6100-318D-48-26-116-4-2200-62
9/21/16 16:07
9/20/16
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOS.VP,GCS-32.890-1-618D-68-53-22-2-53-2-220-13-19-15
4/6/16 17:01
4/5/16
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOS.VP,GCS-13.5200-220D-73-44-33-24-3-4-220-215-14-22-32
3/2/16 16:31
3/1/16
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOS.VP,GCS-23.5100-220D-73-31-43-42-91-9-2-24-5-9-19-32
9/21/15 16:57
9/18/15
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOS.VP,GCS-76.320-1-520D-36-319-3-113-6-32-14-16-22-40-53
7/7/10 16:16
7/2/10
ABIOArca Biopharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOzeroff Christopher DavidCOOSVP,GCM.d00.0600041142D-71221-35-21-21-13-35172417-1-49

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact